Novartis Wins FDA Approval For Its First Meningitis Vaccine As ACIP Is Set To Meet
This article was originally published in The Pink Sheet Daily
Executive Summary
The vaccine targets four serotypes, but not the strain that causes the most cases among infants and toddlers, which is the most lucrative market.
You may also be interested in...
Consumer Group Seeks FTC Investigation Of Sanofi, Merck Vaccine Discounts To Physician Groups
Citizens for Responsibility and Ethics in Washington say Sanofi and Merck contracts require all physicians not to purchase competitors' vaccines in order for their group to get a discount.
Consumer Group Seeks FTC Investigation Of Sanofi, Merck Vaccine Discounts To Physician Groups
Citizens for Responsibility and Ethics in Washington say Sanofi and Merck contracts require all physicians not to purchase competitors' vaccines in order for their group to get a discount.
FDA Letter On Menveo News Release Offers Cautions On Launch Of Expanded Indication
Issued at almost the same time as Novartis submitted an sBLA for vaccination of younger children, FDA's advertising citation criticizes the pacing of an audio news release.